drugset / Trial / NCT01358435
Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects
RandomizedCrossoverQuadruple-blindHealth-services research
Summary
The aim of this trial is to demonstrate bioequivalence of Wosulin 70/30 to Novolin® 70/30 with regard to its total and to its maximum serum insulin concentrations.
Timeline
- Start
- 2011-01
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Novolin 70/30 | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |
| Subject | Wosulin 70N/30R | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |